Are we headed for a repeat of 2022's brutal selloff? While no one can predict the future with certainty, current market trends are raising some ominous red flags.
Cardinal Health (CAH) closed the most recent trading day at $103.37, moving +0.53% from the previous trading session.
Recently, Zacks.com users have been paying close attention to Cardinal (CAH). This makes it worthwhile to examine what the stock has in store.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
The pharmaceutical distribution contract with OptumRx will expire in June.
Cardinal Health Inc. ‘s stock CAH, +2.07% fell 3.6% early Monday, after the pharmaceuticals distributor and medical lab products maker said its contracts with pharmacy benefits manager OptumRx will

Cardinal Health: Solid Business But Overvalued

06:09am, Thursday, 18'th Apr 2024
Cardinal Health is overvalued, with a dividend yield lower than its historical average and a high P/E ratio. Growth projections for the Company are moderate, with a projected growth rate of 7.8% for t
In the latest trading session, Cardinal Health (CAH) closed at $107.03, marking a +1.84% move from the previous day.
CPI, the Consumer Price Index, is a metric used to gauge the rate of inflation and deflation. It's released by the Bureau of Labor Statistics (BLS) and reports the monthly fluctuations in consumer go
Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here we discuss three medical device stocks, Cardinal Health (CAH), Baxter International (BAX) and Fresenius Medical Care (FMS), with a solid five-year dividend growth history.
Cardinal Health (CAH) concluded the recent trading session at $109.47, signifying a -0.41% move from its prior day's close.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE